Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1:2022:21-0192.
doi: 10.1530/EDM-21-0192. Online ahead of print.

Locally invasive classical papillary thyroid carcinoma with TSH receptor I568T mutation: case report

Affiliations

Locally invasive classical papillary thyroid carcinoma with TSH receptor I568T mutation: case report

Jay Nguyen et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

Summary: Autonomous thyroid adenomas are caused by activating mutations in the genes encoding the thyroid-stimulating hormone receptor (TSHR) or mutations in the Gas subunit of the TSHR. Nodules with suspicious sonographic features should be submitted to fine-needle aspiration. Additional molecular testing may be performed to characterize the thyroid nodule's malignant potential further. We present a patient who underwent whole-transcriptome RNA-sequencing that indicated a TSHR I568T mutation after an ultrasound showed suspicious sonographic features and fine-needle aspiration was 'suspicious for malignancy'. The patient underwent thyroid resection and was found to have a locally invasive classical papillary thyroid carcinoma. Most reports of TSHR I568T mutation have been seen in patients with benign thyroid conditions. While there is insufficient data to suggest that the TSHR I568T mutation causes aggressive thyroid malignancy, we believe clinicians who identify the presence of this mutation on genome sequencing should be cautious about the possibility of locally invasive thyroid malignancy, especially when associated with Bethesda V cytopathology.

Learning points: Germline and somatic activating mutations in the genes coding for the thyroid-stimulating hormone receptor (TSHR) have been frequently reported in familial and sporadic autonomous thyroid adenomas and non-autoimmune hyperthyroidism. Most reports of TSHR I568T mutation have been detected in patients with benign thyroid conditions. We present a patient who underwent whole-transcriptome RNA-sequencing that indicated a TSHR I568T mutation and subsequently underwent thyroid resection and was found to have a locally invasive classical papillary thyroid carcinoma. Clinicians who identify the presence of TSHR I568T mutation on genome sequencing should be cautious about the possibility of locally invasive thyroid malignancy, especially when associated with Bethesda V cytopathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biopsy of soft tissue located between the second and third tracheal cartilages on the right anterior portion of the trachea revealed histopathologic findings consistent with locally invasive classical papillary thyroid carcinoma, hematoxylin and eosin, 10×.
Figure 2
Figure 2
Immunohistochemical staining of the same sample was positive for PAX8 (A) and TTF1 (B), 40×.

Similar articles

Cited by

References

    1. Schwab K, Pfarr N, van der Werf-Gohmann N, Pohl M, Radecke J, Musholt T, Pohlenz J. Autonomous thyroid adenoma: only an adult disease? Journal of Pediatrics 2018154931, .e2–933.e2. (10.1016/j.jpeds.2008.12.019) - DOI - PubMed
    1. Nanba K, Usui T, Minamiguchi S, Mori Y, Watanabe Y, Honda K, Asato R, Nakao K, Kawashima ST, Yuno A.et al. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas. Endocrine Journal 20125913–19. (10.1507/endocrj.ej11-0202) - DOI - PubMed
    1. Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngologic Clinics of North America 201043229–23, vii. (10.1016/j.otc.2010.01.002) - DOI - PMC - PubMed
    1. Goldner WS, Angell TE, McAdoo SL, Babiarz J, Sadow PM, Nabhan FA, Nasr C, Kloos RT. Molecular variants and their risks for malignancy in cytologically indeterminate thyroid nodules. Thyroid 2019291594–1605. (10.1089/thy.2019.0278) - DOI - PMC - PubMed
    1. Krane JF, Bibas ES, Endo M, Marqusee E, Hu MI, Nasr CE, Waguespack SG, Wirth LJ, Kloos RT. The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: insights to inform clinical decision-making from a fine-needle aspiration sample. Cancer Cytopathology 2020128452–459. (10.1002/cncy.22300) - DOI - PMC - PubMed

LinkOut - more resources